Differential response of mesenchymal stromal cells (MSCs) to type 1 ex vivo cytokine priming: implications for MSC therapy

Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion

(2022) Akshaya Srinivasan et al.   CYTOTHERAPY

Cytokine Activation Reveals Tissue-Imprinted Gene Profiles of Mesenchymal Stromal Cells

(2022) Danielle M. Wiese et al.   Frontiers in Immunology

Leukemia inhibitory factor protects against graft-versus-host disease while preserving graft-versus-leukemia activity

(2022) Jianming Wang et al.   BLOOD

Priming Mesenchymal Stem/Stromal Cells with a Combination of a Low Dose of IFN-γ and Bortezomib Results in Potent Suppression of Pathogenic Th17 Immunity Through the IDO1-AHR Axis

(2022) Ha Young Park et al.   STEM CELLS

Leukemia inhibitory factor, a double-edged sword with therapeutic implications in human diseases

(2022) Jianming Wang et al.   MOLECULAR THERAPY

Interferon-Gamma Primed Human Clonal Mesenchymal Stromal Cell Sheets Exhibit Enhanced Immunosuppressive Function

(2022) Celia M. Dunn et al.   Cells

Immunomodulatory Properties of Mesenchymal Stromal Cells: An Update

(2021) Luise Müller et al.   Frontiers in Cell and Developmental Biology

Morphological landscapes from high content imaging reveal cytokine priming strategies that enhance mesenchymal stromal cell immunosuppression

(2021) Seth H. Andrews et al.   BIOTECHNOLOGY AND BIOENGINEERING

TNF‐α and IL‐1β sensitize human MSC for IFN‐γ signaling and enhance neutrophil recruitment

(2020) Alexander Hackel et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Mesenchymal stromal cells in hematopoietic cell transplantation

(2020) Andre J. Burnham et al.   Blood Advances

Stem cell therapy in coronavirus disease 2019: current evidence and future potential

(2020) Rohit Shetty et al.   CYTOTHERAPY

Mesenchymal stem cells in allergic diseases: Current status

(2019) He Li et al.   ALLERGOLOGY INTERNATIONAL

Biology and therapeutic potential of interleukin-10

(2019) Margarida Saraiva et al.   JOURNAL OF EXPERIMENTAL MEDICINE

PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo

(2018) Catherine A. Loynes et al.   Science Advances

Mitochondrial Membrane Potential Regulates Nuclear Gene Expression in Macrophages Exposed to Prostaglandin E2

(2018) David E. Sanin et al.   IMMUNITY

Safety Profile of Good Manufacturing Practice Manufactured Interferon γ-Primed Mesenchymal Stem/Stromal Cells for Clinical Trials

(2017) Adam J. Guess et al.   Stem Cells Translational Medicine

Interferon γ induced compositional changes in human bone marrow derived mesenchymal stem/stromal cells

(2017) Qingdong Guan et al.   Clinical Proteomics

Human Amniotic Membrane Mesenchymal Stem Cells inhibit Neutrophil Extracellular Traps through TSG-6

(2017) Fátima Sofía Magaña-Guerrero et al.   Scientific Reports

Suppression of Neutrophil-Mediated Tissue Damage-A Novel Skill of Mesenchymal Stem Cells

(2016) Dongsheng Jiang et al.   STEM CELLS

Human mesenchymal stem cells - current trends and future prospective

(2015) Imran Ullah et al.   BIOSCIENCE REPORTS

limma powers differential expression analyses for RNA-sequencing and microarray studies

(2015) Matthew E. Ritchie et al.   NUCLEIC ACIDS RESEARCH

CREB pathway links PGE2 signaling with macrophage polarization

(2015) Bing Luan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Multifaceted Functions of Neutrophils

(2013) Tanya N. Mayadas et al.   Annual Review of Pathology-Mechanisms of Disease

Regulation of Immune Responses by Prostaglandin E2

(2011) P. Kalinski   JOURNAL OF IMMUNOLOGY

Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair

(2010) Yufang Shi et al.   CELL RESEARCH

Pro-Inflammatory Cytokines, IFNγ and TNFα, Influence Immune Properties of Human Bone Marrow and Wharton Jelly Mesenchymal Stem Cells Differentially

(2010) S. Jyothi Prasanna et al.   PLoS One

A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype

(2010) Ruth S. Waterman et al.   PLoS One